SITC Resource Library

On August 15, 2024, the Society for Immunotherapy of Cancer (SITC) held the third webinar in the new series "Increasing Access to IO: A Global Webinar Series". The recording of the third webinar "Immune Checkpoint Inhibitors: Increasing Access to IO" is available below.
sdaf

Webinar Moderator

• Ahmad A. Tarhini, MD, PhD – H. Lee Moffitt Cancer Center & Research Institute
  
  

Webinar Faculty

• Frederico Perego Costa, MD – Autem Therapeutics, Centro de Oncologia of Hospital Sirio Libanês
• Precious Takondwa Makondi, MBBS, PhD – Kamuzu Central Hospital - National Cancer Center
• Ali Shamseddine, MD – American University of Beirut Medical Center
  sadf

Program Information

The Global Access and Impact Committee, in collaboration with the Diversity, Equity, and Inclusion Committee, is pleased to launch SITC’s first educational program crafted specifically for international audiences, titled “Increasing Access to IO: A Global Webinar Series”. These free digital events will provide a forum for physicians around the globe to discuss challenges and solutions related to critical topics, such as defining biomarkers for PD-L1 positive patients, biomarker assessment for tumor response, cellular therapy and checkpoint inhibitor administration, tumor mutational burden (TMB) and more. Featuring doctors from varying settings around the world, this webinar series offers a unique opportunity to learn about different solutions to immunotherapy application and the barriers currently impeding equitable access to IO. The objective of this webinar series is to create a platform for international stakeholders to discuss critical topics and challenges they face when treating patients with immunotherapy, with a key goal of providing education and bringing awareness to the barriers currently impeding equitable access to IO around the globe. 

sdf

To register for the full series click here. 

asd

#PresentationSlides#RecordedWebinar
#2024